One in 10 clinics in SA will start to hand out a twice-a-year anti-HIV jab as early as February. The country’s medicines ...
Science Africa on MSN
HIV: Challenges Remain as Kenya Set to Rollout Twice-yearly Injectable Drug
By Dickens Okinyi Kenya’s ongoing fight against HIV has entered a new phase with the roll out of Lenacapavir, a groundbreaking long-acting HIV prevention and treatment drug, set to take place in 2026.
The antibody, called 04_A06, blocked 98.5% of more than 300 different HIV strains in lab tests, including many resistant to ...
Zimbabwe has been chosen as one of 10 countries globally to roll out lenacapavir, the world's first twice-yearly injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results